Drug Shortage Report for JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE

Last updated on 2021-04-07 History
Report ID 137069
Drug Identification Number 02418223
Brand name JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE
Common or Proper name Irbesartan HCTZ Tablets
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) IRBESARTAN HYDROCHLOROTHIAZIDE
Strength(s) 150MG 12.5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-10-07
Estimated end date 2022-12-30
Actual end date
Shortage status Actual shortage
Updated date 2021-04-07
Company comments
Health Canada comments
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2021-04-07 French Compare
v1 2021-04-07 English Compare